ISSN: 1948-5948
Journal of Microbial & Biochemical Technology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business
Research Article
Open Access
 
Phenotypic and Biotypic Characterization of Klebsiella oxytoca: An Impact of Biofield Treatment
Mahendra Kumar Trivedi1, Shrikant Patil1, Harish Shettigar1, Khemraj Bairwa2 and Snehasis Jana2*
1Trivedi Global Inc., 10624 S Eastern Avenue Suite A-969, Henderson, NV 89052, USA
2Trivedi Science Research Laboratory Pvt. Ltd., Chinar Fortune City, Bhopal, Madhya Pradesh, India
Corresponding Author : Snehasis Jana
Trivedi Science Research Laboratory Pvt. Ltd., Chinar Fortune City, Bhopal, Madhya Pradesh, India,
Tel: +91-755-6660006
E-mail: publication@trivedisrl.com
Received: June 19, 2015; Accepted: June 24, 2015; Published: July 01, 2015
Citation: Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) Phenotypic and Biotypic Characterization of Klebsiella oxytoca: An Impact of Biofield Treatment. J Microb Biochem Technol 7:202-205. doi:10.4172/1948-5948.1000205
Copyright: © 2015 Trivedi MK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at Pubmed, Scholar Google
Visit for more related articles at Journal of Microbial & Biochemical Technology
 

Abstract

Klebsiella oxytoca (K. oxytoca) is a Gram-negative microbe generally associated with community and hospitalacquired infections. Due to its clinical significance, we evaluated the effect of biofield treatment on phenotype and biotype characteristics of K. oxytoca (ATCC 43165). The study was performed into three groups i.e. C (control), T1 (treatment, revived); and T2 (treatment, lyophilized). Subsequently, groups T1 and T2 were received biofield treatment and control group was remained as untreated. The antimicrobial sensitivity results showed 3.33% and 6.67% alteration in antimicrobials susceptibility in group T1 cells on day 5 and 10, respectively, and 3.33% alteration in antimicrobials susceptibility was observed in group T2 cells on day 10 as compared to control. The sensitivity patterns of cefazolin were changed from resistant (R) to intermediate (I) on day 5, and resistance (R) to susceptible (S) on day 10, in T1 cells of K. oxytoca. The MIC value of cefazolin was decreased by 2-fold in group T1 on day 10 as compared to control. The biofield treated K. oxytoca exhibited the changes in biochemical reactions about 3.03% and 15.15% of total tested biochemicals in group T1 cells on day 5 and 10, respectively as compared to control. The biotype number of K. oxytoca was altered in biofield treated group and organism identified as Raoultella ornithinolytica in T1 on day 10 as compared to control, which is the prominent finding of this study. These changes were found in treated bacteria that might be due to some alteration happened in metabolic/enzymatic pathway and/ or at genetic level of K. oxytoca. Based on these data, it is speculated that biofiled treatment could be an alternative approach that can improve the effectiveness of the existing antimicrobials against the resistant pathogens.

Keywords
Antimicrobials; Biochemicals; Biofield treatment; Biotype; Klebsiella oxytoca
Introduction
Microorganisms like bacteria, viruses, fungi, and parasites are continuously acquiring the resistance against existing antimicrobials that possess a major global threat to public health. In the latest report of World Health Organization (WHO) warned to the occurrence of post-antibiotic era, where people will die from simple microbial infections due to ineffectiveness of current antimicrobials. Frequent and improper use of antimicrobial further accelerated the incidence of microbial resistance [1,2].
Klebsiella oxytoca (K. oxytoca) is a rod-shaped, nonmotile, Gramnegative bacterium with a prominent polysaccharide capsule, which provides a resistance against host defense mechanisms. Klebsiella species are normally associated with the community and hospitalacquired infections particularly in immunocompromised patients. The patients having prostatectomies, neurosurgical procedures, intravascular catheters, colonoscopies, platelet transfusions, urinary tract infections (UTI), and pre-existing viral or antibiotic induced colitis are more prone to K. oxytoca infection [3]. K. oxytoca has developing the enzymes extended spectrum β-lactamases (ESBL) and carbapenemases that lead to bacterial resistance to β-lactam antibiotics. Therefore, K. oxytoca is usually resistant to some antibiotics like cefotaxime, ceftazidime and aztreonam [4,5]. Recently, biofield treatment is reported for the alteration in sensitivity of antimicrobials against the tested microorganism [6].
The conversion of mass into energy is well known in literature for hundreds of years that was further explained by Fritz [7] and Einstein [8]. The energy can exist in various forms like kinetic, potential, electrical, magnetic, and nuclear; and can be produced from different sources. Correspondingly, the nervous system of human also consists of neurons that have the ability to transmit information in the form of electrical signals [9-11]. Thus, human has the ability to harness the energy from environment or universe and can transmit into any living or nonliving object(s) around the globe. The objects always receive the energy and responding into useful way that is called biofield energy and the process is known as biofield treatment.
Mr. Trivedi’s biofield treatment is well-known to change the various physicochemical characteristics of metals and ceramics [12-14]. The quality and yield of several agriculture products have also been improved with several folds in the biofield treated plants [15]. Exposure to biofield energy caused an increase in growth and anatomical characteristics of plant [16]. Further, the biofield treatment has considerably altered susceptibility of antimicrobials and biotype number of microbe [6,17,18].
By conceiving the above mentioned facts and literature reports on biofield, the present work was undertaken to evaluate the impact of biofield treatment on antimicrobials susceptibility, biochemical reactions pattern, and biotype of K. oxytoca.
Materials and Methods
Two lyophilized vials of K. oxytoca [American Type Culture Collection (ATCC) 43165] were procured from MicroBioLogics, Inc., USA. These vials were stored as per the suggested storage conditions till the further use. The antimicrobials susceptibility study, biochemical reactions patterns, and biotype number were evaluated on MicroScan Walk-Away® (Dade Behring Inc., West Sacramento, CA) using Negative Breakpoint Combo 30 (NBPC30) panel [19]. The antimicrobials and biochemicals used in the study were procured from Sigma-Aldrich.
Study design
The lyophilized cells of K. oxytoca were divided into three groups: C (control), T1 (treatment, revived) and T2 (treatment, lyophilized). The treatment groups (T1 and T2) were in sealed pack and handed over to Mr. Trivedi for biofield treatment under laboratory condition. Mr. Trivedi provided the treatment through his energy transmission process to the treated groups without touching the samples. Subsequently, groups C and T1 were assessed on day 5 and 10, and group T2 was assessed on day 10, for the antimicrobial sensitivity, biochemical reactions, and biotype number.
Investigation of antimicrobial susceptibility of microorganism
The antimicrobial susceptibility study was carried out on MicroScan Walk-Away® using negative breakpoint combo 30 (NBPC30) panel, as per manufacturer's instructions. Briefly, the standardized suspension of K. oxytoca were inoculated, rehydrated, and then subjected to incubation for 16 h at 35°C. After that, the susceptibility pattern like susceptible (S), intermediate (I) or resistant (R); and quantitative susceptibility in terms of minimum inhibitory concentration (MIC) were determined by observing the lowest antimicrobial concentration showing growth inhibition [20-22]. The antimicrobials used for the sensitivity study were amikacin, amoxicillin/K-clavulanate, ampicillin/ sulbactam, ampicillin, aztreonam, cefazolin, cefepime, cefotaxime, cefotetan, cefoxitin, ceftazidime, ceftriaxone, cefuroxime, cephalothin, chloramphenicol, ciprofloxacin, gatifloxacin, gentamicin, imipenem, levofloxacin, meropenem, moxifloxacin, nitrofurantoin, norfloxacin, piperacillin, tazobactam, tetracycline, ticarcillin/K- clavulanate, tobramycin, and trimethoprim/sulfamethoxazole.
Study of biochemical reaction
The study of biochemical reactions was carried out on MicroScan Walk-Away® system [23]. The biochemicals used in present work were acetamide, adonitol, arabinose, arginine, cetrimide, cephalothin, citrate, colistin, esculin hydrolysis, nitrofurantoin, glucose, hydrogen sulfide, indole, inositol, kanamycin, lysine, malonate, melibiose, nitrate, oxidation-fermentation, galactosidase, ornithine, oxidase, penicillin, raffinose, rhaminose, sorbitol, sucrose, tartarate, tryptophan deaminase, tobramycin, urea and Voges-Proskauer.
Assessment of biotype number
Effect of biofield treatment on biotype number and organism identification were determined using MicroScan Walk-Away® processed panel data report [20]
Results
Antimicrobial susceptibility assay
The results of antimicrobial susceptibility study and MIC values are summarized in Table 1 and 2, respectively. The results showed about 3.33% and 6.67% alteration in antimicrobials susceptibility in group T1 cells on day 5 and 10, respectively, and 3.33% alteration in antimicrobials susceptibility was found in group T2 cells on day 10 as compared to control. Concisely, the K. oxytoca was converted from S → I against ampicillin/sulbactam in T2 cells on day 10; and R → I and S against cefazolin in T1 cells on day 5 and 10, respectively. The K. oxytoca showed an alteration from S → R against tetracycline in T1 cells on day 10. The MIC data suggested about 2-folds decrease in MIC value of cefazolin, and more than 2-folds increase in MIC value of tetracycline in T1 cells of K. oxytoca on day 10, as compared to control. Furthermore, the susceptibility pattern of K. oxytoca to ampicillin/ sulbactam was also changed from S → I in T2 cell on day 10 with about 2-folds increase in MIC value as compared to control (Table 2).
Identification of K. oxytoca using biochemical reactions pattern
The biochemical reactions data are shown in Table 3. K. oxytoca exhibited an alteration in biochemical reactions about 3.03% and 15.15% of total tested biochemicals on day 5 and 10, respectively. The colistin, nitrofurantoin, hydrogen sulfide, and ornithine were converted from negative (–) to positive (+) reaction in group T1 on day 10, and tartarate was converted from positive (+) to negative (–) reaction in group T1 on both day 5 and 10. The results showed no change in biochemical reactions patterns of group T2 cells, as compared to control (Table 3).
Effect of biofield treatment on biotype number
Biotype number of K. oxytoca was determined on MicroScan Walk-Away® processed panel, using biochemical reactions data. The result demonstrated an alteration in biotype number of K. oxytoca in group T1 on day 10, as compared to control. The change in the species from K. oxytoca to Raoultella ornithinolytica (formerly known as Klebsiella ornithinolytica) was also found in group T1 on day 10 (Table 4), which describes the most significant impact of biofield treatment in this study.
Discussion
Antimicrobial resistance in several microbes has been increased vigorously in recent time. Generally, microorganisms mutate and finally become resistant to antibiotics. Unfortunately, due to improper or misuse of antimicrobials the incidences of antimicrobial resistance in microbes are observing in faster rate than expected [24]. As a result, discovery of antimicrobial drug therapy is a slow and time-consuming process. Recently, there are reports wherein, the susceptibility of microbe was altered from resistance to susceptible or inversely using the biofield treatment [17,18]. Therefore, present work investigates the effect of biofield treatment on K. oxytoca, and evaluated its impact on susceptibility and biochemical reactions pattern to the selected antimicrobials and biochemicals.
Recently, K. oxytoca is acquiring resistant to some cephalosporins and fluoroquinolones antifungal drugs. K. oxytoca have an inherent enzyme β-lactamase that confers a low-level resistance to penicillins. It also carries the efflux pump on the cell wall that causes reduced intracellular concentrations of antimicrobials and induces phenotypic resistance [4,5,25-27]. The sensitivity of K. oxytoca before and after treatment was determined by comparing the MIC value of antimicrobial to the attainable blood or urine level as per the Clinical and Laboratory Standards Institute (CLSI) guideline. The results of antifungal sensitivity study revealed the changes in antimicrobial sensitivity and MIC values of few tested antimicrobials like ampicillin/ sulbactam, cefazolin, and tetracycline against K. oxytoca. Cefazolin is a first-generation cephalosporin that was initially used for wide range of microbial infections. In the present study, K. oxytoca showed resistance to cefazolin in control sample; however, after biofield treatment, the sensitivity was changed from resistant to intermediate and susceptible on 5 and 10 day, respectively. It revealed that using biofield treatment K. oxytoca infection can be effectively overcome by cefazolin. Contrarily, the results also showed the alteration in the sensitivity of K. oxytoca from susceptible to intermediate or resistant to a few antimicrobials. The MIC values of some antimicrobials were also altered accordingly to changes in sensitivity patterns of K. oxytoca. Overall, the result of present study indicated that biofield treatment has the ability to alter the susceptibility of microbes in both direction either susceptible to resistant or resistant to susceptible.
Biochemical methods employed to identify or classify the bacterial species based on their biochemical reactions. Several biochemical tests like indole production, ornithine decarboxylation, and carbon substrate assimilation tests have been reported in literature for the identification of K. oxytoca. It usually exhibited the positive reactions to indole, malonate, urease, Voges-Proskauer; and negative reactions to arginine, colistin, hydrogen sulfide, and ornithin [28]. Similar reactions patterns were also observed in this study for control sample of K. oxytoca. However, after biofield treatment some biochemical reactions pattern were altered like ornithine, hydrogen sulfide, colistin etc. These biochemical were changed from negative to positive reactions in group T1 on day 10. As well, tartarate was converted from positive to negative reaction in group T1 on both day 5 and 10. These data suggested the impact of biofield treatment on metabolic pathway of K. oxytoca. Alterations in biochemical reactions were attributed to changes in biotype number of K. oxytoca that was found in group T1 on day 10. Wherein the biotype number and species were altogether changed and the new species was identified as R. ornithinolytica.
Conclusions
Overall data conclude that there was an alteration in antimicrobial sensitivity, biochemical reactions patterns, and biotype number of biofield treated K. oxytoca. These results depicted that biofield treatment has the ability to make some alteration at the enzymatic or metabolic pathway and/or at genetic level of K. oxytoca. Therefore, in future the biofield treatment could be useful as an alternative method to prevent the infections of pathogenic microbes.
References
























































Tables at a glance

Table icon Table icon Table icon Table icon
Table 1 Table 2 Table 3 Table 4
Select your language of interest to view the total content in your interested language
Share This Article
   
 
   
 
Relevant Topics
Disc Advanced Bioprocess Products
Disc Advances in Bioprocess Technology
Disc Advances in Biotechniques
Disc Advances in Food Bioprocess Technology
Disc Affinity Purification
Disc Agricultural
Disc Agricultural biotechnology
Disc Anaerobic Biodegradation
Disc Analytical Chromatography
Disc Animal and Plant Nutrition
Disc Animal biotechnology
Disc Anthrax
Disc Anti-parasitic Agents
Disc Antibacterial Agents
Disc Antibodies
Disc Antifungal Agents
Disc Antimicrobial Chemotherapy
Disc Antimicrobial Drugs
Disc Antimicrobial Peptide
Disc Antimicrobial Research
Disc Antimicrobial Resistance
Disc Antiprotozoals
Disc Antiseptics
Disc Antiviral Agents
Disc Applied Biotechnology
Disc Aseptic processing
Disc Bacteraemia
Disc Bacterial Ecology
Disc Bacterial Genomics
Disc Bacterial Infections
Disc Bacterial Toxin
Disc Bactericidal Drugs
Disc Bacteriology
Disc Bacteriostatic Drugs
Disc Beneficial Microorganisms in Food
Disc Beverage Industry
Disc Biocatalysis
Disc Biochemical Methods
Disc Biochemical Process
Disc Biochemistry
Disc Biodegradable Balloons
Disc Biodegradable Confetti
Disc Biodegradable Diapers
Disc Biodegradable Plastics
Disc Biodegradable Sunscreen
Disc Biodegradation
Disc Biofertilizers Technology
Disc Biological Activity
Disc Biomaterial implants
Disc Biomedical Chromatography
Disc Biomolecules
Disc Bioprocess Engineering
Disc Bioprocess Industry and Market Analysis
Disc Bioprocess Manufacturing
Disc Bioprocess Modelling
Disc Bioprocess and Systems Engineering
Disc Bioprocessing and Biopharma Manufacturing
Disc Bioremediation Bacteria
Disc Bioremediation Oil Spills
Disc Bioremediation Plants
Disc Bioremediation Products
Disc Biotechnology applications
Disc Blood Biochemistry
Disc Capillary Electrochromatography
Disc Carbohydrate Metabolism
Disc Carbohydrates Biochemistry
Disc Cardiac Markers
Disc Cardiovascular biomaterials
Disc Cellular and molecular Biochemistry
Disc Chromatography
Disc Clinical Biochemistry
Disc Clinical Chemistry
Disc Clinical Microbiology
Disc Coagulase Test
Disc Contamination
Disc Decomposers
Disc Deuterium Exchange Mass Spectrometry
Disc Diagnosis
Disc Diagnosis and treatment of Infectious Disease
Disc Diagnostics
Disc Electrolytes
Disc Electron Capture Dissociation Mass Spectroscopy
Disc Electrophoresis
Disc Electrospray Tandem Mass Spectrometry Newborn Screening
Disc Enzyme Technology
Disc Escherichia coli
Disc Ex Situ Bioremediation
Disc Experimental Food Microbiology
Disc Extraction Chromatography
Disc Fermentation
Disc Fermentation Industrial Microbiology
Disc Filtration
Disc Fishery biochemistry
Disc Food Additives
Disc Food Adulteration
Disc Food Allergens
Disc Food Biochemistry
Disc Food Borne Diseases
Disc Food Contamination
Disc Food Hazards
Disc Food Hygiene
Disc Food Hygiene Regulations
Disc Food Intoxication
Disc Food Labeling
Disc Food Microbes
Disc Food Microbiology
Disc Food Poisoning
Disc Food Quality Assurance
Disc Food Regulations
Disc Food Research International Standards (Food Research Europe, Food Research USA)
Disc Food Safety
Disc Food Safety and Quality
Disc Food Spoilage
Disc Food allergies
Disc Food and Beverage Technology
Disc Food and Feed Chemistry
Disc Food industry
Disc Food poison
Disc Food preservation
Disc Food science technology
Disc Fourier Transform Mass Spectrometry
Disc GC-MS
Disc Gas Chromatography
Disc Gas Chromatography Mass Spectrometry
Disc Germ cell tumours
Disc Good nutrition
Disc HPLC
Disc HPTLC
Disc Heavy Metal Bioremediation
Disc Host-Pathogen Interactions
Disc Imaging Mass Spectrometry
Disc Immuno Affinity Chromatography
Disc In Situ Bioremediation
Disc Industrial Bioprocessing
Disc Industrial Food Microbiology
Disc Industrial Microbiology
Disc Infection Control
Disc Inorganic Chemistry
Disc Inorganic biochemistry
Disc Intestinal Parasites
Disc Ion-exchange chromatography
Disc LC-MS
Disc Leprosy
Disc Liquid Chromatography
Disc Liquid Chromatography Mass Spectrometry
Disc Liquid Liquid Extraction
Disc Listeriosis
Disc Liver Diseases
Disc Liver Function Tests
Disc Lyme Disease
Disc MALDI
Disc Market Analysis of Food Testing
Disc Mass Spectrometry
Disc Mass Spectrometry in Medicine
Disc Mass Spectroscopy in Forensic Studies
Disc Medical Biochemistry
Disc Membrane Biochemistry
Disc Metabolites
Disc Method Validation
Disc Microbial Assay
Disc Microbial Assay of Antibiotic
Disc Microbial Biofuels
Disc Microbial Biosensor
Disc Microbial Fermentation
Disc Microbial Nutrition
Disc Microbiology
Disc Microbiology and Immunology
Disc Microbiology and Immunology Research
Disc Microbiology and Pathology
Disc Microorganism
Disc Minimum Inhibitory Concentration
Disc Morphology
Disc Mycobacterium
Disc Mycology
Disc Mycoremediation
Disc Nano Chemistry
Disc Nano biotechnology
Disc Non Biodegradable
Disc Parasitic Infection
Disc Parasitic Worms
Disc Parasitology
Disc Pasteurisation
Disc Pathogen
Disc Pesticides
Disc Pesticides Biochemistry
Disc Petrochemistry
Disc Pharmaceutical Bioprocessing
Disc Phytoremediation
Disc Pigments
Disc Preparative Biochemistry
Disc Prevention of Contamination
Disc Principles of Diagnosis
Disc Protein Biochemistry
Disc Protein Folding by Mass Spectrometry
Disc Protein Mass Spectrometry
Disc Protein Purification
Disc Renal Function Test
Disc Rickettsioses
Disc Safe Food Handling Practices
Disc Salmonella
Disc Salmonellosis
Disc Selective Pressure
Disc Selective Toxicity
Disc Separation Techniques
Disc Sewage Water Treatment
Disc Soil Biochemistry
Disc Soil Bioremediation
Disc Soil organism
Disc Stem Cell Bioprocessing
Disc Sterilization
Disc Streptococcus
Disc Super Critical Fluid Chromatography
Disc Synthetic High Polymers
Disc Tandem Mass Spectrometry
Disc Transformation
Disc Types of Upwelling
Disc Ultrasound Technologies in Food Industry
Disc Virology
Disc Waste Degredation
Disc White/industrial biotechnology
Disc Xenobiotics
Disc Zoonotic Bacterial Diseases
Disc clinical Microbial Pathology
 
Related Journals
Disc Antimicrobial Agents Journal
Disc Molecular Diagnostics Journal
Disc Medical Biochemistry Journal
Disc Industrial Chemistry Journal
Disc Mass Spectrometry Journal
Disc Chromatography Journal
Disc Molecular Biology Journal
Disc Bioprocessing Journal
Disc Analytical Biochemistry Journal
Disc Food Microbiology Journal
Disc Industrial Microbiology Journal
Disc Biotechnology Journal
Disc Bioremediation Journal
Disc Bacteriology Journal
Disc Medical Microbiology Journal
 
Recommended Conferences
Disc 6th Clinical Microbiology and Microbial Genomics Congress
Oct 24-26, 2016, Rome, Italy
Disc  7th World Congress and Expo onApplied Microbiology
Nov 10-12, 2016, Istanbul, Turkey
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version